Black Diamond Therapeutics, Inc.
Ticker: 1701541
values in millions
| Period | Q1 FY25 |
|---|---|
| INCOME | |
| Revenue | 70.00 |
| Total Income | 70.00 |
| EXPENSES | |
| Expenditure | 15.47 |
| Tax | 0.23 |
| PROFIT | |
| Net Profit | 56.54 |
| KEY METRICS | |
| OPM % | 77.90% |
| NPM % | 80.77% |
| EPS | 1.00 |
Corporate Events
Board MeetingBDTX
202626Jun
Board Meeting
Voting results from the 2026 Annual Meeting of Stockholders,…
SEC Filing ↗